Sugi Predict

Sugi Predict / Compounds / SCHEMBL3181285

SCHEMBL3181285

SCHEMBL3181285

C[C@]12CC[C@H]3[C@@H](CCC4=C[C@H](O)CC[C@@H]43)[C@@H]1CC[C@@H]2O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SHBG P04278 5/20 0.65
▸ SERPINA6 P08185 3/20 0.65
▸ SLC22A1 O15245 2/20 0.65
▸ ALDH1A1 P00352 2/20 0.65
▸ THRB P10828 1/20 0.65
▸ PDK1 Q15118 2/20 0.62
▸ PDK2 Q15119 2/20 0.62
▸ PDK3 Q15120 2/20 0.62
▸ PDK4 Q16654 2/20 0.62
▸ ESR1 P03372 6/20 0.62
▸ ESR2 Q92731 5/20 0.62
▸ LMNA P02545 4/20 0.47
▸ MEN1 O00255 3/20 0.47
▸ MAPT P10636 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ GAA P10253 2/20 0.47
▸ G6PD P11413 2/20 0.47
▸ PKM P14618 2/20 0.47
▸ MAPK1 P28482 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21807739 1.00 SHBG (0.65) SHBGSERPINA6SLC22A1ALDH1A1THRB
SCHEMBL4925553 1.00 SHBG (0.65) SHBGSERPINA6SLC22A1ALDH1A1THRB
SCHEMBL6655376 1.00 SHBG (0.65) SHBGSERPINA6SLC22A1ALDH1A1THRB
SCHEMBL6448963 1.00 SHBG (0.65) SHBGSERPINA6SLC22A1ALDH1A1THRB
SCHEMBL6575174 1.00 SHBG (0.65) SHBGSERPINA6SLC22A1ALDH1A1THRB
SCHEMBL6573913 1.00 SHBG (0.65) SHBGSERPINA6SLC22A1ALDH1A1THRB
SCHEMBL6575143 1.00 SHBG (0.65) SHBGSERPINA6SLC22A1ALDH1A1THRB
SCHEMBL547771 1.00 SHBG (0.65) SHBGSERPINA6SLC22A1ALDH1A1THRB
Propionic Acid SCHEMBL634971 0.91 PDK1 (0.60) SHBGSERPINA6SLC22A1ALDH1A1THRB
SCHEMBL4321179 0.87 SHBG (0.50) SHBGSERPINA6SLC22A1ALDH1A1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115926192-B Bio-based powder coating and preparation method thereof 江南大学 2023-07-07 — — CN claimed
US-20070042040-A1 Methods and compositions using gonadotropin hormone releasing hormone DEBIOPHARM S.A. (CH) 2007-02-22 — — US claimed
EP-1617859-A1 METHODS AND COMPOSITIONS USING GONADOTROPIN HORMONE RELEASING HORMONE DEBIOPHARM S.A. (CH) 2006-01-25 — — EP claimed
US-20050282732-A1 Pharmaceutical compositions and treatment methods-7 BIOVIE INC. 2005-12-22 — — US claimed
US-20050159366-A1 Pharmaceutical compositions and treatment methods - 8 BIOVIE INC. 2005-07-21 — — US claimed
WO-2005063276-A1 METHODS AND COMPOSITIONS USING GONADOTROPIN HORMONE RELEASING HORMONE DEBIOPHARM S.A. (CH) 2005-07-14 — — WO claimed
WO-2004096259-A1 METHODS AND COMPOSITIONS USING GONADOTROPIN HORMONE RELEASING HORMONE DEBIOPHARM S.A. (CH) 2004-11-11 — — WO claimed
US-20040220161-A1 Pharmaceutical compositions and treatment methods-6 BIOVIE INC. 2004-11-04 — — US claimed
WO-2003002058-A9 BONE ANABOLIC COMPOUNDS AND METHODS OF USE ANABONIX INC (US) 2004-07-08 — — WO claimed
EP-1422234-A2 Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone Hollis-Eden Pharmaceuticals Inc. (US) 2004-05-26 — — EP claimed
EP-1404344-A2 BONE ANABOLIC COMPOUNDS AND METHODS OF USE Anabonix, Inc. (US) 2004-04-07 — — EP claimed
US-20030134828-A1 Composition and method for increasing in vivo androgen concentration ROBERTS WILLIAM J (US) 2003-07-17 — — US claimed
US-20030134831-A1 Bioavailable prodrugs of androgenic steroids and related method BIOTEST LABORATORIES, LLC 2003-07-17 — — US claimed
US-20030119800-A1 Bone anabolic compounds and methods of use BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS 2003-06-26 — — US claimed
WO-2003002058-A2 BONE ANABOLIC COMPOUNDS AND METHODS OF USE ANABONIX, INC. (US) 2003-01-09 — — WO claimed
EP-4114275-B1 SYSTEMS AND METHODS FOR FLUID SAMPLE COLLECTION AND TESTING Marshall Venture Partners LLC (US) 2025-07-30 — — EP disclosed
US-12324839-B2 Testosterone-inducing peptide compounds and associated combinations ACESIS BIOMED US, INC. (US) 2025-06-10 — — US disclosed
US-20030119800-A1 Bone anabolic compounds and methods of use BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS 2003-06-26 — — US disclosed
WO-2003002058-A2 BONE ANABOLIC COMPOUNDS AND METHODS OF USE ANABONIX, INC. (US) 2003-01-09 — — WO disclosed
US-20020183532-A1 Bioavailable prodrugs of androgenic steroids and related method BIOTEST LABORATORIES, LLC 2002-12-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050282732-A1 Pharmaceutical compositions and treatment methods-7 HSD17B7, IL17A, HSD3B1 SHBG 52/4885SERPINA6 64/4885SLC22A1 2233/4885
US-20040220161-A1 Pharmaceutical compositions and treatment methods-6 HSD17B7, HSD3B1, NR5A1 SHBG 41/4885SERPINA6 33/4885SLC22A1 1630/4885
US-20050159366-A1 Pharmaceutical compositions and treatment methods - 8 HSD17B7, NR5A1, HSD3B1 SHBG 37/4885SERPINA6 60/4885SLC22A1 2615/4885
US-20030134828-A1 Composition and method for increasing in vivo androgen concentration SHBG, CYP21A2, CYP19A1 SHBG 1/4885SERPINA6 108/4885SLC22A1 768/4885
US-20030119800-A1 Bone anabolic compounds and methods of use SHBG, BMP2, BMP4 SHBG 1/4885SERPINA6 50/4885SLC22A1 2809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback